The report considers revenue generated by the sales of self-monitoring blood glucose devices products such as blood glucose meters, lancets, and test strips. However, the report does not include revenue generated by related drugs used in management of diabetic patients and continuous glucose monitoring systems. Moreover, the study excludes the market estimates for artificial pancreas systems.

CHAPTER 1: INTRODUCTION 

CHAPTER 2: EXECUTIVE SUMMARY 

CHAPTER 3: MARKET OVERVIEW

CHAPTER 4: SMART PILLS MARKET, BY APPLICATION

CHAPTER 5: SMART PILLS MARKET, BY TARGET AREA

CHAPTER 6: SMART PILLS MARKET, BY DISEASE INDICATION

CHAPTER 7: SMART PILLS MARKET, BY END USER

CHAPTER 8: SMART PILLS MARKET, BY REGION

CHAPTER 9: COMPANY PROFILES